PeptidePedia The community reference

Source of Personal importation policy

Page source·read-only·revision 26

Editing is disabled on this mirror. This is the page source as of revision 26, saved by FigureFerdinand on 18 July 2026. It is shown so that the markup behind the rendered article can be read and reused under the PeptidePedia Wiki Content Licence (PPCL-BY-SA 4.0).

4,121 bytes · 60 lines · 3 top-level sections · 4 defined citations. The markup grammar is documented at Project:Manual of style.

{{Infobox concept | name = Personal importation policy | subtitle = Importation | Nature = Enforcement discretion, not permission | Varies by = Jurisdiction, substance, quantity, declared purpose | Outcome if not applied = Detention, refusal, or [[Customs seizure|seizure]] }} '''Personal importation policy''' describes the discretion some regulators exercise not to pursue enforcement against small quantities of a medicine imported by an individual. It is a statement about how an authority intends to use its resources, not a right of importation and not permission.{{r|fda_pip}} The conditions typically named include a quantity consistent with personal use, a substance not otherwise prohibited, and an absence of commercial character. Meeting them does not guarantee entry; a consignment may still be refused. See [[Customs seizure]].{{r|fda_pip}} Policies differ substantially between jurisdictions and are revised. This wiki describes the mechanism and does not advise on the legality of any transaction; see [[Regulatory status by jurisdiction]].{{r|wco}} == Discretion is not permission == A policy of this kind states that an authority does not ordinarily act in defined circumstances. It does not change the underlying legal position, and it can be changed without legislation.{{r|fda_pip}} The practical consequence is asymmetric: a person relying on such a policy has no entitlement if it is not applied, and no remedy if a consignment is refused. Goods are not usually returned. Research chemicals occupy a different category again. A substance imported as a laboratory reagent rather than as a medicine is subject to different rules, and the declared purpose is part of what determines which rules apply.{{r|wco}} == What varies between jurisdictions == | Variable | Typical range | |---|---| | Whether a policy exists | Some jurisdictions have none | | Quantity treated as personal | Weeks to a few months of supply | | Prescription requirement | Sometimes required for the policy to apply | | Prohibited categories | Controlled substances always excluded | | Practical enforcement | Varies with resources and priorities | The gap between the written policy and observed practice is often wide in both directions, which is why community reports of consignments arriving or being stopped are weak evidence about what any policy says.{{r|reports}} Federal systems add a further layer where sub-national law differs from national law.{{r|wco}} == Interaction with material quality == Importation policy has nothing to do with the quality of what is imported. A consignment released is not thereby vouched for and one refused is not thereby impugned. See [[Customs seizure]].{{r|fda_pip}} The one practical link is storage. A consignment detained for any period has left its [[Cold-chain freight|cold chain]], and any subsequent [[Third-party testing|independent result]] characterises the journey as well as the manufacture. See [[Chain of custody]].{{r|reports}} This wiki sells nothing, gives no legal advice, and does not describe means of avoiding border controls. Research-use compounds are not approved for human administration.{{r|usp1503}} == References == {{reflist}} <ref name="fda_pip">United States Food and Drug Administration, ''Regulatory Procedures Manual'', chapter 9 (coverage of personal importations).</ref> <ref name="wco">World Customs Organization, ''International Convention on the Simplification and Harmonization of Customs Procedures'' (revised Kyoto Convention).</ref> <ref name="reports">PeptidePedia Wiki community test-report tally, 2024–2026 (self-reported; see [[Project:Sourcing_guidelines]]).</ref> <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, ''Quality Attributes of Synthetic Peptide Drug Substances''.</ref> == See also == * [[Customs seizure]] * [[Regulatory status by jurisdiction]] * [[Grey market]] * [[Cold-chain freight]] * [[Research use only]] {{DEFAULTSORT:Personal importation policy}} [[Category:Importation and customs]] [[Category:Regulation and law]] [[Category:Legal status by jurisdiction]]

Templates in this source are rendered by the site generator: {{r|id}} becomes a numbered citation, {{figure|key|caption}} a framed diagram, {{main|Title}} a cross-reference line.